FDA Inspection
Huntington Reproductive Center Medical GroupHuntington Reproductive Center Medical Group – FDA Inspection, Oct 29, 2024
Record Details
This FDA Inspection record concerns Huntington Reproductive Center Medical Group, with an inspection on October 29, 2024, issued by the Los Angeles District Office, covering biologics.
- Inspection Date
- October 29, 2024
- Product Type
- Biologics
View Company Profile
ID · 0fb0f23e-1aa5-4e9f-b9cb-f44821eb33da
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1253031
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
FDA Citations
2- 21 CFR 1271.50(a)Determination based on screening and testing
- 21 CFR 1271.55(c)Name and personal info on accompanying records
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Huntington Reproductive Center Medical Group
3| Date | Classification | Office | Project area |
|---|---|---|---|
| March 28, 2023 | NAI | Center for Biologics Evaluation and Research | Vaccines and Allergenic Products |
| March 23, 2018 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| September 9, 2015 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for Huntington Reproductive Center Medical Group
- FDA Inspection 1201073 - 2023-03-28
- FDA Inspection 1056321 - 2018-03-23
- FDA Inspection 941285 - 2015-09-09
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.